|
EP1802332A2
|
|
Modified hiv-1 envelope proteins
|
|
AU2003294297A8
|
|
Recombinant hiv-1 subclass d envelope glycoproteins
|
|
CA2485490A1
|
|
Respiratory referenced imaging
|
|
EP1456830A1
|
|
Multi-tactile display haptic interface device
|
|
WO03042968A1
|
|
Method and system for presenting real time physiological information through a head mounted display
|
|
WO03057824A2
|
|
Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
|
|
EP1450667A2
|
|
Cardiac gating method and system
|
|
WO02082357A1
|
|
Pixelation reconstruction for image resolution and image data transmission
|
|
WO02078434A1
|
|
Murine model of dermatitis
|
|
WO02081656A2
|
|
Enhanced diagnostic potential of prostate-specific antigen expressing cells
|
|
EP1370644A2
|
|
Materials and methods for the induction of premature chromosome condensation
|
|
AU2002243977A1
|
|
Immortalized human prostatic cancer cell lines
|
|
WO02064018A2
|
|
Immortalized human familial prostatic cancer cell lines
|
|
AU1798402A
|
|
Erythropoietin and erythropoietin receptor expression in human cancer
|
|
AU7844000A
|
|
Chromosome alterations in prostate cancer
|
|
WO0123526A1
|
|
Engineered radiation resistant bioremediating bacteria
|
|
CA2259961A1
|
|
Protein and peptide vaccines for inducing mucosal immunity
|
|
USRE37525E
|
|
Method for treating infectious respiratory diseases
|
